Photon-Mediated Electron Emitter Device, Shycocan, Launched to Combat Covid-19

India: Medwin Healthcare, Kolkata based healthcare company launched Scalene Hypercharge Corona Canon (SHYCOCAN) today. This device uses Photon-Mediated Electron Emitters to kill pathogens in air, including Corona Virus.

Dr Rajah Vijay Kumar, the Inventor of Shycocan, scientist and Chairman & Chief Scientific Officer, Organization de Scalene and Scalene Cybernetics Ltd., Bengaluru along with Debashis Bose, CEO, Medwin Healthcare & Dhrubajyoti Bose, CFO, Medwin Healthcare were present during the virtual launch.

Speaking on the workings of the device, Dr Kumar, said, “Shycocan is proven to be 99.9% effective in neutralising the Spike-Protein or S-protein that are present in coronavirus. The device is designed to release a very high concentration of environmentally safe electrons using proprietary Photon-Mediated Electron Emitters (PMEEs) made with a super alloy developed by us, to emit and excite photons with the required kinetic energy. As the high energy photons bombard bulk surfaces and suspended particles in confined environments, the electron cloud actively ‘disarms’ air and surface transmission of the Corona family of viruses. Even if an infected individual were to walk into the room, these electrons would neutralise the potency of the virus present in aerosols while sneezing or coughing.”

Shycocan has fulfilled the conditions laid down by European Union- CE and the device is market enabled as per the U.S. FDA’s enforcement discretion guidance during the COVID- 19 Public Health Emergency. Shycocan can be used to prevent infection and is not medicine or an alternative to a vaccine that can cure infected people. It has been designed by a team led by Dr Kumar, who had earlier designed Cytotron, a machine to treat cancer more effectively. The device is effective in closed spaces of up to 1,000 sq ft or in places up to 10,000 cubic metres, such as waiting rooms, offices, malls and other public areas. The basic principle behind the technology is to disable the homing mechanism on the virus and prevent infection. Shycocan does not harm any living organism, be it a fungi or a human. It can be used in all environments and does not have any detrimental effects. The device does not alter or interrupt any other services and functions, be it telephone calls or internet connections.

During the virtual session, Debashis Bose, CEO, Medwin Healthcare, said, “Medwin Healthcare is producing and distributing the devices across India. We are planning to sell around 1,30,000 device in the next six months.  By the end of FY 21 we are looking for a revenue of 250 crore.”

Dhrubajyoti Bose, CFO, Medwin Healthcare further added, “Shycocan will enable us to create a safer environment in homes, offices, healthcare facilities, schools, eateries, etc. The device has been priced, keeping in mind, that the maximum strata of our society can afford it.”